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Summary
Objective: To determine whether dimethylmethylene blue (DMMB) analysis, when combined with agarose gel ﬁltration chromatography
(Superose 6), can be performed instead of ﬂuorophore-assisted carbohydrate electrophoresis (FACE) to determine chondroitin sulfate
(CS) chain length in synovial ﬂuid (SF).
Methods: SF was obtained from (1) normal horses after 8 weeks of rest, (2) the same horses after 9 months of treadmill training, and (3) horses
with osteochondral (OC) injury from racing. SF CS concentrations and chain lengths were determined by gel chromatography and DMMB
analysis and compared with previous results determined by FACE analysis on the same samples.
Results: DMMB analysis showed that SF CS peak chain length in the OC injury group increased signiﬁcantly (18.7 kDa) when compared to
rested and exercised normal horses (15.6 kDa). The assay had a positive predictive value of 71% and a negative predictive value of 75% for
discriminating between normal and injured joints.
Conclusions: We report a simple and inexpensive DMMB analysis of SF CS chain length, which, when coupled with Superose 6 chromato-
graphy, discriminates between normal and post-injury joints. Similar to our previous FACE analysis results [Brown MP, Trumble TN, Plaas AHK,
Sandy JD, Romano M, Hernandez J, et-al. Exercise and injury increase chondroitin sulfate chain length and decrease hyaluronan chain length
in synovial ﬂuid. Osteoarthritis Cartilage 2007;15], our DMMB results show an increase in the chain length of the CS in the SF of injured joints.
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Chondroitin sulfate (CS) has been widely studied as a bio-
marker to monitor changes in the metabolism of joints2e7.
We have shown previously, by sequential use of agarose
gel ﬁltration chromatography (Superose 6) and ﬂuoro-
phore-assisted carbohydrate electrophoresis (FACE), that
CS chains in synovial ﬂuid (SF) from injured joints are sig-
niﬁcantly longer than those in normal joints1. Thus, determi-
nation of SF CS chain length has potential application as
a biomarker of joint injury. Unfortunately, FACE is a tech-
nique that requires specialized laboratory equipment and
a high level of technical expertise. Additionally, FACE tech-
nique is expensive in terms of materials and time per sam-
ple. The aim of the present study was to determine whether
dimethylmethylene blue (DMMB) analysis could be used in-
stead of FACE to determine CS chain length in SF. If so, the
more practical DMMB would make determination of SF CS
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screening tool.
Methods, results and discussion
SF was obtained from carpal joints of (1) eight normal
Thoroughbred horses (3e6 years of age) after 8 weeks of
rest, (2) the same horses after 9 months of treadmill train-
ing, and (3) seven Thoroughbred horses (3e6 years of
age) with osteochondral (OC) injury from racing. Speciﬁ-
cally, OC injuries are small OC fracture fragments from
the dorsal articular margins of the carpal bones and are
traumatic in origin. The protocol was approved by the Insti-
tutional Animal Care and Use Committee. Superose 6 chro-
matography and FACE analysis had previously been
performed on these samples1.
Aliquots (250 ml) of SFs were digested with proteinase K
(1 mg proteinase K/sample; GIBCO, Carlsbad, CA), fol-
lowed by enzyme inactivation at 100C for 10 min and ﬁltra-
tion through a 0.45 mm nylon membrane. Samples were
then fractionated on gel ﬁltration columns (HR 10/30; GE
Healthcare, Pittsburgh, PA) packed with agarose (Superose
6; GE Healthcare) as previously described1. Column43
1444 M. P. Brown et al.: CS chain lengthefﬂuent was collected in 1 ml fractions by using a fraction
collector (GE Healthcare). Fractions 1 through 13 were dis-
carded and fractions 14 through 23 were collected for
DMMB analysis (10 fractions per joint). The Superose 6 col-
umn was previously calibrated for CS molecular weight8.
Our previous work has shown that the sulfated glycosami-
noglycans (GAGs) contained in these fractions are CS1.
Fractions (1 ml) were vacuum dried and reconstituted in
100 ml of water. DMMB was performed by modiﬁcation of
the Blyscan method (Biocolor, Accurate Chemical
Supplies, Westbury, NY), adapted to a 384-well microplate
technique. Blyscan dye reagent (1 ml) was added to each
sample, shaken for 30 min, then centrifuged (13,000 g) for
20 min. Supernatant was decanted with care not to disturb
the precipitate. Tubes were inverted on paper towel and
allowed to drain. Blyscan dissociation reagent was added
based on the anticipated amount of GAGs in the sample
(300 ml for fractions 14 through 16 and 21 through 23;
600 ml for fractions 17 through 20), and the sample vortexed
brieﬂy. Chondroitin-4-sulfate standards (Biocolor) and sam-
ples (60 ml aliquots) were pipetted into a 384-well microplate
(Fisher, Pittsburgh, PA) and absorbance was read at
650 nm, using a microplate reader (FLUOstar OPTIMA,
BMG Labtech, Inc., Durham, NC).
Average molecular weights (kDa) of CS chains in individ-
ual fractions from the Superose 6 column were estimated by
the relationship between the experimentally determined
number of repeating disaccharides and the partition coefﬁ-
cient (KD) for the column used, as previously described
8.
Partition coefﬁcient (KD) was estimated from
KD ¼ VeV0
Vt V0
where Ve is the elution volume of the fraction, V0 is the void
volume of the column and Vt is the total volume of the col-
umn9. The molecular mass of the typical CS disaccharide
unit was assumed to be 446 Da8.
The DMMB assay measures total sulfated GAGs10.
Therefore, in order to compare DMMB results directly with
FACE results, we used total sulfated chondroitin disaccha-
ride (Ddi6S and Ddi4S) determined by FACE for the same
samples1. Values for non-sulfated chondroitin disaccharide
(Ddi0S) from the FACE analysis were excluded from the
comparison because DMMB does not detect non-sulfated
GAGs10. Area under the curve (AUC) for total GAG concen-
tration was compared between the two assay methods by
the Wilcoxon matched-pairs signed-ranks test, with
P< 0.05 considered signiﬁcant. Fisher’s exact test was
used to determine the sensitivity, speciﬁcity, positive predic-
tive value, and negative predictive value of using the SF CS
chain length to discriminate between OC injured and normal
(rested and exercised values combined) joints.
Sulfated GAG from SF was quantitated in mg/ml of ﬂuid by
DMMB, according to fragment size (Superose 6 fraction
number). Figure 1(A) shows mean (þSD) SF CS content
of the three groups as determined by DMMB. For compari-
son, Fig. 1(B) shows mean (þSD) total sulfated chondroitin
disaccharide (Ddi6S and Ddi4S) for the same samples
determined by FACE. For both methods, the CS peak
occurred at fraction #18 (18.7 kDa) in SF from joints with
OC injury. Similarly, CS in SF from exercised joints peaked
in fraction #19 (15.6 kDa) with both assays. CS in SF from
rested joints peaked in fraction #19 (15.6 kDa) when deter-
mined by DMMB, but peaked in fraction #20 (11.6 kDa)
when measured by FACE [Fig. 1(A) and (B)]. When AUC
values were compared between the two assay methodsfor the OC injury and exercised groups, the DMMB tech-
nique yielded signiﬁcantly higher AUC values than FACE.
However, the two assays yielded similar AUC values for
the rested group (Table I).
Low volumes of DMMB reagents could be used with
a 384-well microplate, facilitating quantitation of the small
amounts of CS in fractions collected from Superose 6 chro-
matography. When used for quantitation of sulfated CS in
Fig. 1. (A)Mean (þSD)CS concentrations in fractions of SF from res-
ted and exercised horses with normal joints and from horseswith OC
injury. (B)Mean (þSD) total sulfated chondroitin disaccharide (Ddi6S
and Ddi4S) for the same samples determined by FACE. Superose 6
fraction at which peak occurs forOC injury (red arrows), rested (black
arrows), and exercised (blue arrows).
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those from FACE analysis. Although it is possible that
DMMB may be measuring other sulfated GAGs in addition
to CS, this is unlikely, because our previous FACE analysis
results have shown that CS and hyaluronan are the only
GAGs in these Superose 6 fractions1. Keratan sulfate is
eluted from the column in later fractions (data not shown)
and therefore should not be contributing to sulfated GAGs
measured by the DMMB assay. Therefore, we expect that
CS is the only sulfated GAG being measured by DMMB in
these fractions. Similar to our previous FACE analysis
results1, our DMMB results show an increase in the chain
length of the CS in the SF of OC injured joints when com-
pared to rested and exercised horses.
Although the Superose 6/DMMB assay has low sensitivity,
its speciﬁcity is higher andmore comparable to the FACE as-
say in which Ddi6S and Ddi4S values were combined
(Table II). The usefulness of an assay is often deﬁned by
its positive and negative predictive values. Positive predic-
tive value gives the probability that a joint classiﬁed as posi-
tive by the assay is indeed injured. Conversely, negative
predictive value gives the probability that a joint that is
classiﬁed as negative by the assay is really normal. These
values were calculated by using Superose 6 fraction 18
as a breakpoint for OC injured joints and Superose 6
fraction 19 as a breakpoint for normal joints (rested and ex-
ercised values combined). This yielded a positive predictive
value of 71% and a negative predictive value of 75% for the
DMMB assay, compared with a positive predictive value of
86% and a negative predictive value of 94% for the FACE
assay when values for Ddi6S and Ddi4S were combined to
allow a direct comparison between the assays. Improved
predictive values were seen for FACE when each disaccha-
ride was considered separately in a previous study1.
In summary, when combined with Superose 6 chroma-
tography, DMMB assay was less accurate than FACE in
discriminating between SF from OC injured and normal
joints. The lower accuracy of DMMB is probably related to
the fact that the measured sulfated GAG (presumed to be
CS) is less well deﬁned than the CS disaccharides mea-
sured by FACE. However, the DMMB assay is much
Table II
Sensitivity, specificity, positive predictive value, and negative pre-
dictive value of DMMB and FACE assays of SF CS chain length
to discriminate between OC injured (Superose fraction B18) and
normal (Superose fraction B19; rested and exercised values
combined) joints
Assay Sensitivity
(%)
Speciﬁcity
(%)
Positive
predictive
value (%)
Negative
predictive
value (%)
DMMB 56 86 71 75
FACE 86 94 86 94
Table I
AUC (SD) for each group and assay (mg of CS/ml of SF)
Assay OC injury* Rested Exercised*
DMMB 52.5 3.0 24.3 1.3 43.3 2.4
FACE 21.3 1.4 26.5 2.4 28.6 2.9
*AUC values for OC injury and exercised joints were signiﬁcantly
different between assays (P< 0.0001), but values for rested joints
were not (P¼ 0.92).more practical than FACE because it requires less time, ex-
pense, and technical expertise. Thus, it would be more
readily adapted to routine use and may be useful as
a screening tool for both research and clinical applications.
Therefore, our described DMMB microplate assay, when
coupled with Superose 6 chromatography, may provide
a simple and inexpensive tool for determining CS chain
length in evaluation of joint health.
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